AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational GDNF gene therapy for Parkinson's disease

Source :: European Union News. July 11, 2024
Publication Year :: 2024
Abstract: Germany: Bayer AG has issued the following press release: Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer [...]

Subjects :: United States. Food and Drug Administration -- Innovations
Bayer AG -- Product development
Independent regulatory commissions
Genes
Diseases -- Drug therapy -- Germany -- United Kingdom
Passports
Gene therapy
Pharmaceutical industry -- Product development
Business, international

Tools